Phase II-III: A multicenter trial of Abagovomab maintenance therapy in patients with epithelial ovarian cancer after complete response to first line chemotherapy
| Type of clinical trial
|
Vaccine clinical trial |
| Recruiting project
|
No
|
| Orpha number
|
ORPHA101172 |
| Status
|
Ongoing trial
|
|
| Geographic coverage
|
Global |
| Funding body(ies)
|
- |
| Sponsor
|
Menarini ricerche s.p.a. |
|
Principal investigator of clinical trial :
Pr Giovanni SCAMBIA
Centro di Ricerca e Formazione ad Alta tecnologia nelle Scienze Biomediche
Dipartimento di Oncologia
Università Cattolica di Campobasso
Contrada Tappino
86100 CAMPOBASSO
ITALY
More information
|
Phone
: 39 0874 312447
Fax
: 39 0874 312324
Website
|
The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.
